About Focus Pharmaceuticals
Provider of geospatial data and aerial imagery services. This includes aerial photography, scan services for analog images, and aerotriangulation. They also create and process geospatial data, offering orthophotos, topographic maps, 3D terrain models derived from aerial or laser scan data, and 3D city models. Further services encompass specialized geospatial data such as green space inventories, property records with outdoor facilities, and solar potential analyses based on 3D models or laser scan data. WebGIS solutions for data visualization and analysis are also provided.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Amdipharm Mercury
(Oct 01, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Focus Pharmaceuticals
Detailed funding history for Focus Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Focus Pharmaceuticals
Focus Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Amdipharm Mercury.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A diversified portfolio of off-patent drugs is provided.
|
Locked | Locked | Locked |
Investor details for Focus Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Focus Pharmaceuticals
Investment portfolio details for Focus Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Focus Pharmaceuticals
Detailed financials for Focus Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Focus Pharmaceuticals Comparisons
Peer comparison for Focus Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Focus Pharmaceuticals
Detailed competitors of Focus Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Focus Pharmaceuticals
Complete news archive for Focus Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Focus Pharmaceuticals
Focus Pharmaceuticals was founded in 2002.
Focus Pharmaceuticals is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Mark Cresswell is the current CEO of Focus Pharmaceuticals.
Provider of geospatial data and aerial imagery services. This includes aerial photography, scan services for analog images, and aerotriangulation. They also create and process geospatial data, offering orthophotos, topographic maps, 3D terrain models derived from aerial or laser scan data, and 3D city models. Further services encompass specialized geospatial data such as green space inventories, property records with outdoor facilities, and solar potential analyses based on 3D models or laser scan data. WebGIS solutions for data visualization and analysis are also provided.
Focus Pharmaceuticals has 1 investor. Key investors include Amdipharm Mercury.